These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30004037)

  • 21. Involvement of kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats.
    Yuan C; Huang WQ; Guo JH; Liu XY; Yang JZ; Chen JJ; Wu Y; Ruan YC; Liu JY; Cui YG; Diao FY; Chan HC
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166242. PubMed ID: 34389474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic transcriptional expression of the kisspeptin system and sex steroid receptors differs among polycystic ovary syndrome rat models with different endocrine phenotypes.
    Marcondes RR; Carvalho KC; Giannocco G; Duarte DC; Garcia N; Soares-Junior JM; da Silva IDCG; Maliqueo M; Baracat EC; Maciel GAR
    Clinics (Sao Paulo); 2017 Aug; 72(8):510-514. PubMed ID: 28954011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
    BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS).
    Wang T; Han S; Tian W; Zhao M; Zhang H
    Gynecol Endocrinol; 2019 Sep; 35(9):807-810. PubMed ID: 30957568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
    Hu Q; Jin J; Zhou H; Yu D; Qian W; Zhong Y; Zhang J; Tang C; Liu P; Zhou Y; Wang X; Sheng L
    Biomed Pharmacother; 2018 Nov; 107():1363-1369. PubMed ID: 30257351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques.
    Branavan U; Muneeswaran K; Wijesundera S; Jayakody S; Chandrasekharan V; Wijeyaratne C
    PLoS One; 2018; 13(12):e0209830. PubMed ID: 30596735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kisspeptin levels in relation to sex hormone profile among PCOS patients.
    Zarei E; Binabaj MM; Zadeh FM; Bakhshandeh Nosrat S; Veghari G; Mansourian A
    Ir J Med Sci; 2022 Aug; 191(4):1711-1716. PubMed ID: 34378162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Almuammar MN; Al Neghery LM; Warsy AS
    Br J Biomed Sci; 2020 Oct; 77(4):185-190. PubMed ID: 32031919
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models.
    Risvanli A; Ocal H; Timurkaan N; Ipek P; Seker I; Karabulut B
    Bosn J Basic Med Sci; 2020 Feb; 20(1):37-43. PubMed ID: 31782699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kisspeptin mRNA expression is increased in the posterior hypothalamus in the rat model of polycystic ovary syndrome.
    Matsuzaki T; Tungalagsuvd A; Iwasa T; Munkhzaya M; Yanagihara R; Tokui T; Yano K; Mayila Y; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 Jan; 64(1):7-14. PubMed ID: 27665725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of kisspeptin in polycystic ovarian syndrome: A metabolomics study.
    Zhao T; Xiao X; Li L; Tao X; He W; Zhang Q; Wu X; Yuan T
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):315-325. PubMed ID: 36843187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome.
    Coutinho EA; Esparza LA; Rodriguez J; Yang J; Schafer D; Kauffman AS
    Hum Reprod; 2024 Sep; 39(9):2089-2103. PubMed ID: 38978296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of kisspeptin-positive cells in the hypothalamus of a rat model of polycystic ovary syndrome.
    Kondo M; Osuka S; Iwase A; Nakahara T; Saito A; Bayasula ; Nakamura T; Goto M; Kotani T; Kikkawa F
    Metab Brain Dis; 2016 Jun; 31(3):673-81. PubMed ID: 26864582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction.
    Rashad NM; Al-Sayed RM; Yousef MS; Saraya YS
    Diabetes Metab Syndr; 2019; 13(3):2086-2092. PubMed ID: 31235141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.
    Dungan HM; Clifton DK; Steiner RA
    Endocrinology; 2006 Mar; 147(3):1154-8. PubMed ID: 16373418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of leptin receptor and kisspeptin/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity.
    Zhai L; Zhao J; Zhu Y; Liu Q; Niu W; Liu C; Wang Y
    Endocrine; 2018 Oct; 62(1):195-206. PubMed ID: 29948931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.